NEUROLOGIX, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for NEUROLOGIX, INC..The latest application filed is for "novel glutamic acid decarboxylase (gad) chimera and methods of use".

Company Profile

0.9.14

NEUROLOGIX, INC. - Fort Lee NJ
NEUROLOGIX, INC. - Floral Park NY
Neurologix, Inc. - New York NY
Neurologix, Inc. - Great Neck NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use App 20120071546 - Fitzsimons; Helen ; et al.	2012-03-22
Use Of Apoptosis Inhibiting Compounds In Degenerative Neurological Disorders App 20120039991 - Kaplitt; Michael ; et al.	2012-02-16
Glutamic acid decarboxylase (GAD) chimera and methods of use Grant 8,071,563 - Fitzsimons , et al. December 6, 2	2011-12-06
Use of apotosis inhibiting compounds in degenerative neurological disorders Grant 8,017,385 - Kaplitt , et al. September 13, 2	2011-09-13
Glutamic Acid Decarboxylase (gad) Based Delivery System App 20110207802 - During; Matthew ; et al.	2011-08-25
Glutamic acid decarboxylase (GAD) based delivery system Grant 7,955,595 - During , et al. June 7, 2	2011-06-07
Methods And Compositions For The Treatment Of Neurological Disease App 20100168215 - During; Matthew J. ; et al.	2010-07-01
Glutamic Acid Decarboxylase (gad) Based Delivery System App 20100143458 - During; Matthew ; et al.	2010-06-10
Methods and compositions for the treatment of neurological disease Grant 7,723,288 - During , et al. May 25, 2	2010-05-25
High Transgene Expression Of A Pseudotyped Adeno-Associated Virus Type App 20100093058 - Liu; Yuhong ; et al.	2010-04-15
Glutamic acid decarboxylase (GAD) based delivery systems Grant 7,695,959 - During , et al. April 13, 2	2010-04-13
Glutamic acid decarboxylase (GAD) based delivery system Grant 7,645,446 - During , et al. January 12, 2	2010-01-12
Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use App 20090233994 - Fitzsimons; Helen ; et al.	2009-09-17
Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity App 20090214637 - Musatov; Sergey	2009-08-27
Glutamic acid decarboxylase (GAD) chimera and methods of use Grant 7,527,785 - Fitzsimons , et al. May 5, 2	2009-05-05
Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity App 20090110661 - Musatov; Sergey	2009-04-30
Novel glutamic acid decarboxylase (GAD) proteins and methods of use App 20090098631 - Fitzsimons; Helen Lisa ; et al.	2009-04-16
PINK-1 promoter App 20060228776 - Kaplitt; Michael ; et al.	2006-10-12
Use of apotosis inhibiting compounds in degenerative neurological disorders App 20060210538 - Kaplitt; Michael ; et al.	2006-09-21
Glutamic acid decarboxylase (GAD) based delivery system App 20060099179 - During; Matthew ; et al.	2006-05-11
Glutamic acid decarboxylase (GAD) based delivery systems App 20050025746 - During, Matthew ; et al.	2005-02-03
Glutamic acid decarboxylase (GAD) based delivery system Grant 6,780,409 - During , et al. August 24, 2	2004-08-24
Helper functions for recombinant vector production Grant 6,329,181 - Xiao , et al. December 11, 2	2001-12-11

Company Registrations

NCAGE Code	4T6R9	NEUROLOGIX INC.!DBA A DEVELOPMENT STAGE COMPANY
CAGE Code	4T6R9	NEUROLOGIX, INC. (A DEVELOPMENT STAGE COMPANY)
SEC	0001170857	NEUROLOGIX INC
SEC	0000356591	NEUROLOGIX INC/DE of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.